Presynaptic prostaglandin E2 EP1-receptor facilitation of cerebral nitrergic neurogenic vasodilation

Stroke

Volumn 40, Issue 1, 2009, Pages 261-269

  Jadhav, Vikram ^a,c   Jabre, Anthony ^b   Chen, Mei Fang ^d   Lee, Tony Jer Fu ^a,d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Cyclo oxygenase (COX); Parasympathetic neurotransmission; Perivascular nitrergic nerves; Porcine cerebral arteries; Presynaptic EP1 receptor; Prostaglandin E2 (PGE2)

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; ATROPINE; CALCIUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EP1 RECEPTOR; GUANETHIDINE; NAPROXEN; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OMEGA CONOTOXIN; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SALICYLIC ACID; SC 51322; UNCLASSIFIED DRUG; CALCIUM CHANNEL BLOCKING AGENT; ISOMERASE; PROSTAGLANDIN E RECEPTOR; PROSTANOID RECEPTOR EP1;

ANIMAL CELL; ANIMAL TISSUE; ARTERY TONE; ARTICLE; BASILAR ARTERY; BRAIN BLOOD VESSEL; CALCIUM TRANSPORT; CONTROLLED STUDY; GANGLION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; NERVE STIMULATION; NEUROTRANSMISSION; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; VASODILATATION; ANIMAL; AUTONOMIC NERVE; BRAIN ARTERY; BRAIN CIRCULATION; CALCIUM SIGNALING; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; INNERVATION; METABOLISM; NITRERGIC NERVE; PARASYMPATHETIC GANGLION; PHYSIOLOGY; SWINE; ULTRASTRUCTURE;

ANIMALS; AUTONOMIC PATHWAYS; BASILAR ARTERY; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELLS, CULTURED; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIBENZ(B,F)(1,4)OXAZEPINE-10(11H)-CARBOXYLIC ACID, 8-CHLORO-, 2-ACETYLHYDRAZIDE; DINOPROSTONE; GANGLIA, PARASYMPATHETIC; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; NITRERGIC NEURONS; NITRIC OXIDE SYNTHASE TYPE I; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, PROSTAGLANDIN E; SUS SCROFA; VASODILATION;

EID: 60549098085     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.516104     Document Type: Article

References (51)

1. Gulbenkian S, Uddman R, Edvinsson L. Neuronal messengers in the human cerebral circulation. Peptides. 2001;22:995-1007.
2. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res. 1990;66:8-17.
3. Ayajiki K, Okamura T, Toda N. Neurogenic relaxations caused by nicotine in isolated cat middle cerebral arteries. J Pharmacol Exp Ther. 1994;270:795-801.
4. Lee TJF. Putative transmitters in cerebral neurogenic vasodilation. In: Bevan RD, Bevan JA, Walters CL, eds. The Human Brain Circulation: Functional Changes in Disease. Totowa, NJ: Humana Press; 1994:73-91.
5. Kimura T, Yu JG, Edvinsson L, Lee TJF. Cholinergic, nitric oxidergic innervation in cerebral arteries of the cat. Brain Res. 1997;773:117-124.
6. Zhang W, Edvinsson L, Lee TJF. Mechanism of nicotine-induced neurogenic vasodilation in the porcine basilar artery. J Pharmacol Exp Ther. 1998;284:790-797.
7. Toda N. Relaxant responses to transmural stimulation and nicotine of dog and monkey cerebral arteries. Am J Physiol. 1982;243:H145-H153.
8. Okamura T, Ayajiki K, Fujioka H, Shinozaki K, Toda N. Neurogenic cerebral vasodilation mediated by nitric oxide. Jpn J Pharmacol. 2002;88: 32-38.
9. Gonzalez C, Barroso C, Martin C, Gulbenkian S, Estrada C. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries. J Cereb Blood Flow Metab. 1997;17:977-984.
10. Si ML, Lee TJ. Alpha7-nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation. Circ Res. 2002;91:62-69.
11. Liu J, Lee TJ. Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in cerebral arteries. Am J Physiol. 1999;276:H194-H204.
12. Lee TJ, Liu J, Evans MS. Cholinergic-nitrergic transmitter mechanisms in the cerebral circulation. Microsc Res Tech. 2001;53:119-128.
13. Lee TJ. Sympathetic modulation of nitrergic neurogenic vasodilation in cerebral arteries. Jpn J Pharmacol. 2002;88:26-31.
14. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res. 2001;89:650-660.
15. Dumont I, Hou X, Hardy P, Peri KG, Beauchamp M, Najarian T, Molotchnikoff S, Varma DR, Chemtob S. Developmental regulation of endothelial nitric oxide synthase in cerebral vessels of newborn pig by prostaglandin E(2). J Pharmacol Exp Ther. 1999;291:627-633.
16. Li DY, Hardy P, Abran D, Martinez-Bermudez AK, Guerguerian AM, Bhattacharya M, Almazan G, Menezes R, Peri KG, Varma DR, Chemtob S. Key role for cyclooxygenase-2 in PGE2 and PGF2alpha receptor regulation and cerebral blood flow of the newborn. Am J Physiol. 1997; 273:R1283-R1290.
17. Jadhav V, Jabre A, Lin SZ, Lee TJ. EP1-and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries. J Cereb Blood Flow Metab. 2004;24:1305-1316.
18. 2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase. J Trauma. 1998;44:777-782.
19. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000;20:907-918.
20. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
21. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate- mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A. 2001;30:98:1294-1299.
22. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med. 2006;12:225-229.
23. Saleem S, Li RC, Wei G, Dore S. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J Neurosci Res. 2007;85:2433-2440.
24. Ahmad AS, Saleem S, Ahmad M, Dore S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci. 2006;89:265-270.
25. Liu D, Wu L, Breyer R, Mattson MP, Andreasson K. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol. 2005;57:758-761.
26. Malik KU, Sehic E. Prostaglandins and the release of the adrenergic transmitter. Ann N Y Acad Sci. 1990;604:222-236.
27. Serio R, Daniel EE. Eicosanoids and peripheral neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 1989;38:237-246.
28. Gullner HG. The interactions of prostaglandins with the sympathetic nervous system-a review. J Auton Nerv Syst. 1983;8:1-12.
29. Lee TJ. Cholinergic mechanism in the large cat cerebral artery. Circ Res. 1982;50:870-879.
30. Shibuya I, Tanaka K, Uezono Y, Ueta Y, Toyohira Y, Yanagihara N, Izumi F, Yamashita H. Prostaglandin E2 induces Ca2+ release from ryanodine/caffeine- sensitive stores in bovine adrenal medullary cells via EP1-like receptors. J Neurochem. 1999;73:2167-2174.
31. Kojima H, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Tanaka J, Kudo Y, Nagano T. Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA. Neuroreport. 1998; 26:3345-3348.
32. Ishine T, Yu JG, Asada Y, Lee TJ. Nitric oxide is the predominant mediator for neurogenic vasodilation in porcine pial veins. J Pharmacol Exp Ther. 1999;289:398-404.
33. Tran Dinh YR, Jomaa A, Callebert J, Reynier-Rebuffel AM, Tedgui A, Savarit A, Sercombe R. Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage. Neurosurgery. 2001;48:626-633.
34. Yamamoto R, Wada A, Asada Y, Yanagita T, Yuhi T, Niina H, Sumiyoshi A, Kobayashi H, Lee TJ. Nitric oxide-dependent and-independent norepinephrine release in rat mesenteric arteries. Am J Physiol. 1997;272:H207-H210.
35. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 2000;275:32775-32782.
36. Wendling WW, Harakal C. Effects of prostaglandin F2 alpha and thromboxane A2 analogue on bovine cerebral arterial tone and calcium fluxes. Stroke. 1991;22:66-72.
37. Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA. EP4 prostanoid receptormediated vasodilatation of human middle cerebral arteries. Br J Pharmacol. 2004;141:580-585.
38. Abran D, Dumont I, Hardy P, Peri K, Li DY, Molotchnikoff S, Varma DR, Chemtob S. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development. Circ Res. 1997;80:463-472.
39. Harder DR, Roman RJ, Gebremedhin D. Molecular mechanisms controlling nutritive blood flow: role of cytochrome P450 enzymes. Acta Physiol Scand. 2000;168:543-549.
40. Phillis JW, Horrocks LA, Farooqui AA. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev. 2006;52:201-243.
41. Faraci FM, Sobey CG, Chrissobolis S, Lund DD, Heistad DD, Weintraub NL. Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K( + ) channels. Am J Physiol Regul Integr Comp Physiol. 2001;281:R246-R253.
42. Boehm S, Huck S. Receptors controlling transmitter release from sympathetic neurons in vitro. Prog Neurobiol. 1997;51:225-242.
43. Sakai M, Minami T, Hara N, Nishihara I, Kitade H, Kamiyama Y, Okuda K, Takahashi H, Mori H, Ito S. Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2. Br J Pharmacol. 1998;123:890-894.
44. Kopp UC, Cicha MZ. PGE2 increases substance P release from renal pelvic sensory nerves via activation of N-type calcium channels. Am J Physiol. 1999;276:R1241-R1248.
45. Deckers IA, Rampart M, Bult H, Herman AG. Evidence for the involvement of prostaglandins in modulation of acetylcholine release from canine bronchial tissue. Eur J Pharmacol. 1989;167:415-418.
46. +2-dependent, calmodulin-independent mechanism. Brain Res. 1988;441:339-351.
47. Liu J, Evans MS, Lee TJ. Presynaptic muscarinic M(2)-receptor-mediated inhibition of N-type Ca(2 + ) channels in cultured sphenopalatine ganglion: direct evidence for acetylcholine inhibition of cerebral nitrergic neurogenic vasodilation. J Pharmacol Exp Ther. 2002;302:397-405.
48. Smith AB, Cunnane TC. Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors. Br J Pharmacol. 1998;123:167-172.
49. Tabata H, Tanaka S, Sugimoto Y, Kanki H, Kaneko S, Ichikawa A. Possible coupling of prostaglandin E receptor EP(1) to TRP5 expressed in Xenopus laevis oocytes. Biochem Biophys Res Commun. 2002;298:398-402.
50. Stefanovic B, Bosetti F, Silva AC. Modulatory role of cyclooxygenase-2 in cerebrovascular coupling. Neuroimage. 2006;32:23-32.
51. Wang H, Hitron IM, Iadecola C, Pickel VM. Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. Cereb Cortex. 2005;15:1250-1260.